Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer
T Takenaka, M Takenoyama… - European Journal of …, 2015 - academic.oup.com
OBJECTIVES The impact of epidermal growth factor receptor (EGFR) status and the use of
EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy have not been well discussed only in …
EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy have not been well discussed only in …
Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer
T Takenaka, M Takenoyama… - … Journal of Cardio …, 2015 - kyushu-u.elsevierpure.com
OBJECTIVES: The impact of epidermal growth factor receptor (EGFR) status and the use of
EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy have not been well discussed only in …
EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy have not been well discussed only in …
[PDF][PDF] Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer
T Takenakaa, M Takenoyamaa… - European Journal of …, 2015 - academia.edu
OBJECTIVES: The impact of epidermal growth factor receptor (EGFR) status and the use of
EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy have not been well discussed only in …
EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy have not been well discussed only in …
[引用][C] Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer
T Takenaka, M Takenoyama, M Yamaguchi… - European Journal of …, 2014 - cir.nii.ac.jp
Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival
of patients with surgically resected non-small-cell lung cancer | CiNii Research CiNii 国立 …
of patients with surgically resected non-small-cell lung cancer | CiNii Research CiNii 国立 …
Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer
T Takenaka, M Takenoyama… - … journal of cardio …, 2015 - pubmed.ncbi.nlm.nih.gov
Objectives The impact of epidermal growth factor receptor (EGFR) status and the use of
EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy have not been well discussed only in …
EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy have not been well discussed only in …
Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer.
T Takenaka, M Takenoyama, M Yamaguchi… - European Journal of …, 2014 - europepmc.org
Objectives The impact of epidermal growth factor receptor (EGFR) status and the use of
EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy have not been well discussed only in …
EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy have not been well discussed only in …
Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer†.
T Takenaka, M Takenoyama… - … Journal of Cardio …, 2015 - search.ebscohost.com
OBJECTIVES The impact of epidermal growth factor receptor (EGFR) status and the use of
EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy have not been well discussed only in …
EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy have not been well discussed only in …